LINDSAY HOUGHTON: Open Payments
NPI 1881188183 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 16 payments from 10 companies in 2025. Trend: 2023 $680 · 2024 $365 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| SANOFI PASTEUR INC. | 1 | $123 |
| ABBVIE INC. | 5 | $96 |
| Soleno Therapeutics, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Corium, LLC | 1 | $21 |
| Phadia US Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: BEYFORTUS, VRAYLAR, VYKAT XR, Ozempic, NEFFY, FUROSCIX, CAPLYTA, Azstarys.
Industry payments across VA — which companies pay providers there.
